Acadia Pharmaceuticals | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
ALKERMES USD 92.98M 79.19M 2025-06
Alnylam Pharmaceuticals USD -16199000 34.28M 2025-06
Biogen USD 851.8M 540.6M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Corcept Therapeutics USD 26.67M 23.26M 2025-06
Cytokinetics USD -111506000 44.12M 2025-06
Eisai JPY 20.74B 21.77B 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Incyte USD 310.82M 105.66M 2025-06
J&J USD 6.94B 6.69B 2025-06
Moderna USD -907000000 143M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Prothena USD -64897000 1.62M 2024-12
PTC Therapeutics USD -34858000 1.01B 2025-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Vertex Pharmaceuticals USD 1.15B 123.1M 2025-06


Acadia Pharmaceuticals Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.